Discover
Rx for Biotech
Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment

Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment
Update: 2025-08-21
Share
Description
In this episode of Rx for Biotech, host Chris Leidli sits down with Dr. Frank Bedu-Addo, CEO of PDS Biotechnology, to discuss how the company is reimagining immunotherapy with its proprietary Versamune® T-cell activating platform.
Comments
In Channel



